Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.

OBJECTIVE--To determine whether diabetic patients admitted with acute myocardial infarction have impaired fibrinolytic activity due to raised plasminogen activator inhibitor compared with non-diabetic patients. SETTING--A district general hospital. PATIENTS--90 non-diabetic and 38 diabetic patients...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Br Heart J
Principais autores:	Gray, R P, Yudkin, J S, Patterson, D L
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1024985/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8461220/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.69.3.228
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!